TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
Resmed Inc, a company listed on the NYSE, has filed a Form 144 for the proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing indicates that Jan De Witte, a director of the company, plans to sell 2,055 shares of common stock, with an aggregate market value of $524,025. The shares were acquired through restricted stock vesting, with the sale expected to occur on November 25, 2025. This transaction reflects ongoing insider trading activities and may have implications for the company’s stock liquidity and market perception.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,211,977
Technical Sentiment Signal: Buy
Current Market Cap: A$56.58B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.